• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wherefore interferon?

作者信息

Gresser I

机构信息

Laboratory of Viral Oncology, Centre National de la Recherche Scientifique, Villejuif, France.

出版信息

J Leukoc Biol. 1997 May;61(5):567-74. doi: 10.1002/jlb.61.5.567.

DOI:10.1002/jlb.61.5.567
PMID:9129205
Abstract

Interferon (IFN) was discovered by virologists interested in the phenomenon of viral interference and for many years was considered to be exclusively an antiviral substance. In time, it was accepted that the antiviral action was only one manifestation of the multiple effects of IFN on cells. IFN was shown to inhibit the development of tumors, to modulate immune function, and even to induce disease. Some aspects of these phenomena will be discussed. Despite this plethora of biological effects of type I IFN, the potency of its antiviral action, combined with its varied effects on both the cell-mediated and humoral immune response, render it a most effective and remarkable antiviral substance. Arguments will be presented to support the hypothesis that the major role of IFN is, after all, in antiviral defense. Finally, the use of type I IFN in the treatment of patients with viral and neoplastic diseases and even diseases of varied and unknown etiology is discussed.

摘要

相似文献

1
Wherefore interferon?
J Leukoc Biol. 1997 May;61(5):567-74. doi: 10.1002/jlb.61.5.567.
2
Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.仙台病毒C蛋白中最小的Y2蛋白,完全能够对抗干扰素的抗病毒作用并抑制病毒RNA合成。
J Virol. 2001 Apr;75(8):3802-10. doi: 10.1128/JVI.75.8.3802-3810.2001.
3
Somnogenic effects of rabbit and recombinant human interferons in rabbits.兔干扰素及重组人干扰素对兔的促眠作用
Am J Physiol. 1994 Jul;267(1 Pt 2):R53-61. doi: 10.1152/ajpregu.1994.267.1.R53.
4
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.1型白蛋白融合干扰素(白蛋白-干扰素-α和白蛋白-干扰素-β)对生物恐怖主义的RNA病毒制剂和严重急性呼吸综合征(SARS)病毒具有强大的体外活性。
Chemotherapy. 2008;54(3):176-80. doi: 10.1159/000140361. Epub 2008 Jun 18.
5
Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections.吲哚胺-2,3-双加氧酶在α/β干扰素和γ干扰素介导的抗单纯疱疹病毒感染抗病毒效应中的作用
J Virol. 2004 Mar;78(5):2632-6. doi: 10.1128/jvi.78.5.2632-2636.2004.
6
Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons.α、β和γ干扰素介导的抗丙型肝炎病毒活性及基因表达的比较分析
J Virol. 2002 Nov;76(21):11148-54. doi: 10.1128/jvi.76.21.11148-11154.2002.
7
Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.CHO-SS细胞衍生的人ω干扰素及其他人类干扰素对丙型肝炎病毒RNA复制子和相关病毒的抗病毒活性。
Antiviral Res. 2007 Feb;73(2):118-25. doi: 10.1016/j.antiviral.2006.08.005. Epub 2006 Sep 11.
8
Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].重组甲硫氨酸干扰素-con1、干扰素-α2b和干扰素-β的体外宿主范围比较[已修正]
J Interferon Cytokine Res. 1995 Mar;15(3):231-4. doi: 10.1089/jir.1995.15.231.
9
[Update on the use of interferons in clinical practice].[干扰素在临床实践中的应用进展]
Clin Ter. 1995 Jun-Jul;146(6-7):393-448.
10
Human interferons alpha, beta and omega.人α、β和ω干扰素。
Growth Factors. 2004 Dec;22(4):243-51. doi: 10.1080/08977190400000833.

引用本文的文献

1
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.APS-1 患者中预先存在的 I 型干扰素自身抗体是导致严重 COVID-19 肺炎的基础。
J Exp Med. 2021 Jul 5;218(7). doi: 10.1084/jem.20210554.
2
TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons.TLR3 控制人成纤维细胞和皮质神经元的固有 IFN-β 抗病毒免疫。
J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI134529.
3
Integrated Analysis of Key Pathways and Drug Targets Associated With Vogt-Koyanagi-Harada Disease.
Vogt-Koyanagi-Harada 病相关关键通路和药物靶点的综合分析。
Front Immunol. 2020 Dec 15;11:587443. doi: 10.3389/fimmu.2020.587443. eCollection 2020.
4
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
5
Molecular characterization and expression of type-I interferon gene in Labeo rohita.印度鲤鱼I型干扰素基因的分子特征与表达
Mol Biol Rep. 2014 May;41(5):2979-87. doi: 10.1007/s11033-014-3155-0. Epub 2014 Jan 22.
6
PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH₂-terminal kinase activation.蛋白激酶C-δ通过激活c-Jun氨基末端激酶介导干扰素-α诱导的细胞凋亡。
BMC Cell Biol. 2012 Mar 21;13:7. doi: 10.1186/1471-2121-13-7.
7
Inborn errors of anti-viral interferon immunity in humans.人类抗病毒干扰素免疫的先天缺陷。
Curr Opin Virol. 2011 Dec;1(6):487-96. doi: 10.1016/j.coviro.2011.10.016.
8
Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.α/β干扰素通过限制细胞嗜性和增强神经元存活来预防西尼罗河病毒致死性感染。
J Virol. 2005 Nov;79(21):13350-61. doi: 10.1128/JVI.79.21.13350-13361.2005.
9
Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.肿瘤坏死因子相关凋亡诱导配体在小鼠对流感病毒感染的免疫反应中的作用。
J Virol. 2005 Jun;79(12):7658-63. doi: 10.1128/JVI.79.12.7658-7663.2005.
10
The role of IL-12, IL-23 and IFN-gamma in immunity to viruses.白细胞介素-12、白细胞介素-23和γ干扰素在病毒免疫中的作用。
Cytokine Growth Factor Rev. 2004 Oct;15(5):367-77. doi: 10.1016/j.cytogfr.2004.03.009.